Latest Atorvastatin Stories
Patients with rheumatoid arthritis (RA) who discontinue use of statin therapy are at increased risk of death from cardiovascular disease and other causes.
A novel monoclonal antibody identified in a new study dramatically lowered circulating LDL cholesterol by 40 percent to 72 percent, a development with potential to provide a new option for patients who are resistant to cholesterol-lowering drugs such as statins or to the current standard of care.
Researchers are trying to find the answers to cholesterol! In three phase 1 trials, they analyzed how PCSK9 binds to LDL receptors and will lead to their accelerated degradation and to increased LDL cholesterol levels.
- totally perplexed and mixed up.